Preclinical and clinical perspectives on the use of estramustine as an antimitotic drug
- 31 December 1992
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 56 (3), 323-339
- https://doi.org/10.1016/0163-7258(92)90023-s
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Evidence for a non-estrogenic cytostatic effect of estramustine on human prostatic carcinoma cells in vivoThe Prostate, 1992
- A phase I trial of taxol given by a 6-hour intravenous infusion.Journal of Clinical Oncology, 1991
- Phosphorylation of Microtubule Proteins in Rat Brain at Different Developmental Stages: Comparison with That Found in Neuronal CulturesJournal of Neurochemistry, 1990
- Mechanisms by which mammalian cells acquire resistance to drugs that affect microtubule assemblyThe FASEB Journal, 1989
- Effect of estramustine phosphate on the assembly of trypsin-treated microtubules and microtubules reconstituted from purified tubulin with either tau, MAP2, or the tubulin-binding fragment of MAP2Archives of Biochemistry and Biophysics, 1987
- Estramustine Phosphate Compared with Diethylstilbestrol A Randomized, Double-Blind, Crossover Trial for Stage D Prostate CancerAmerican Journal of Clinical Oncology, 1986
- A reevaluation of nonhormonal cytotoxic chemotherapy in the treatment of prostatic carcinoma.Journal of Clinical Oncology, 1985
- Estramustine Phosphate Therapy in Carcinoma of the ProstatePublished by Springer Nature ,1977
- COLD‐LABILE AND COLD‐STABLE MICROTUBULES IN THE MITOTIC SPINDLE OF MAMMALIAN CELLS*Annals of the New York Academy of Sciences, 1975
- Vinblastine and microtubules: I. Induction and isolation of crystals from sea urchin oocytesExperimental Cell Research, 1971